Year | Donation Number | Number of confirmed positive samples Prevalence /100000 donation (95%CI) | |||||||
---|---|---|---|---|---|---|---|---|---|
First time | Regular | ||||||||
HBV | HIV | HCV | HTLV | HBV | HIV | HCV | HTLV | ||
2010 | 354,695 | 975,275 (240–310) | 8 2.3 (1.5–3.4) | 162 45.7 (41.6–50) | 379,106.9 (100.6–1134) | 56 15.8 (13.5–18.5) | 0 | 17 4.8 (3.6–6.4) | 47 13.3 (11.2–15.8) |
2011 | 351,769 | 840,224.9 (215.8–234.4) | 6 1.6 (0.9–2.6) | 163 43.6 (39.6–47.8) | 358 95.7 (89.8–101.9) | 41 11.7 (9.7–14.2) | 7 2 (1.3–3) | 23 6.5 (5.1–8.3) | 29 8.2 (6.6–10.2) |
2012 | 393,317 | 723,184.4 (176.2–193) | 5 1.3 (0.75–2.2) | 147 37.5 (33.8–41.4) | 263 67.1 (62.2–72.4) | 17 4.3 (3.2–5.8) | 2 0.5 (0.2–1.2) | 7 1.8 (1.1–2.8) | 23 5.8 (4.5–7.5) |
2013 | 391,210 | 659,168.5 (160.6–176.7) | 5 1.3 (0.75–2.2) | 151 38.6 (34.9–42.6) | 276 70.6 (65.5–76) | 8 2 (1.3–3) | 0 | 14 3.6 (2.6–5) | 13 3.3 (2.3–4.6) |
2014 | 405,133 | 630,153.1 (145.6–160.9) | 5 1.2 (0.7–2) | 117 28.4 (25.2–31.9) | 292 71 (65.9–76.4) | 42 10.4 (8.6–12.6) | 3 0.7 (0.3–1.4) | 16 3.9 (2.8–5.3) | 19 4.7 (3.5–6.2) |
2015 | 429,629 | 593,143.6 (136.3–156.2) | 4 1 (0.54–1.8) | 111 26.9 (23.8–30.3) | 242 58.8 (54.2–63.7) | 62 14.4 (12.7–17) | 3 0.7 (0.3–1.4) | 18 4.2 (3.1–5.7) | 6 1.4 (0.8–2.3) |
2016 | 419,665 | 471,112.2 (105.8–118.9) | 10 2.4 (1.6–3.5) | 111 26.4 (23.4–29.7) | 239 57 (52.5–61.8) | 19 4.5 (3.4–6) | 2 0.5 (0.2–1.2) | 11 2.6 (1.8–3.8) | 13 3.1 (2.2–4.4) |
2017 | 432,097 | 347 80.3 (74.9–86) | 3 0.7 (0.3–1.4) | 86 19.9 (17.3–22.9) | 176 40.7 (36.9–44.8) | 11 2.5 (1.7–3.7) | 2 0.5 (0.2–1.2) | 9 2.1 (1.4–3.2) | 16 3.7 (2.7–5.1) |
2018 | 445,345 | 298 66.9 (62–72.2) | 4 0.9 (0.4–1.7) | 61 13.7 (11.6–16.2) | 137 30.8 (27.5–34.4) | 12 2.7 (1.8–3.9) | 4 0.9 (0.4–1.7) | 4 0.9 (0.4–1.7) | 9 2 (1.3–3) |
Total | 3,622,860 | 5536 152.8 (145.3–160.6) | 50 1.4 (0.8–2.3) | 1109 30.6 (27.3–34.2) | 2362 65.2 (60.4–70.4) | 268 7.4 (6–9.3) | 23 0.6 (0.3–1.3) | 119 3.3 (2.5–4.6) | 175 4.8 (3.6–6.4) |